EyePoint Pharmaceuticals, Inc.
Develops innovative, sustained-delivery therapeutics for retinal diseases.
EYPT | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 480 PLEASANT STREET, 2472 WATERTOWN
- Website:
- https://eyepointpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat serious retinal diseases. The company's core strategy centers on its proprietary and proven Durasert E™ technology, a platform for sustained, intraocular drug delivery designed to improve patient outcomes and reduce treatment burden. Its pipeline includes the investigational product DURAVYU™ (EYP-1901) for VEGF-mediated retinal diseases. The Durasert® technology has been successfully utilized in multiple FDA-approved ophthalmic products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all EyePoint Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyePoint Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyePoint Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
